currency test online Top stories

The Korea Composite Index closed up 1.60%.Zhongjing Technology: Changzhou Jinhong, a shareholder, intends to reduce its shareholding by no more than 3%. Zhongjing Technology announced that Changzhou Jinhong Enterprise Management Partnership (Limited Partnership), a shareholder holding more than 5%, intends to reduce its shareholding in the company by means of centralized bidding and block trading, with the reduction amount not exceeding 18,886,100 shares, that is, not exceeding 3% of the company's total share capital. The reduction price will be determined according to the market price when the reduction is implemented. This reduction will be carried out within three months after 15 trading days from the date of disclosure of this announcement.The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)

The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)After the European Central Bank announced the interest rate decision, EUR/USD rose 15 points to 1.0484.Korean media: The director of the South Korean Police Department who was arrested in an emergency for "civil strife" was sent to the hospital due to the deterioration of his health. According to Yonhap News Agency's latest news from the police on the 12th, Zhao Zhihao, the director of the South Korean Police Department who was arrested in an emergency on suspicion of "civil strife" in the early morning of the 11th, has been sent to the hospital for treatment due to the deterioration of his health. (World Wide Web)

COMEX silver fell 1.00% in the day and is now quoted at $32.63 per ounce.Zhongjing Technology: Changzhou Jinhong, a shareholder, intends to reduce its shareholding by no more than 3%. Zhongjing Technology announced that Changzhou Jinhong Enterprise Management Partnership (Limited Partnership), a shareholder holding more than 5%, intends to reduce its shareholding in the company by means of centralized bidding and block trading, with the reduction amount not exceeding 18,886,100 shares, that is, not exceeding 3% of the company's total share capital. The reduction price will be determined according to the market price when the reduction is implemented. This reduction will be carried out within three months after 15 trading days from the date of disclosure of this announcement.The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)